When is tirzepatide patent expire?

When does tirzepatide’s patent protection end?

Tirzepatide (the active ingredient in Mounjaro and Zepbound) is protected by multiple patents covering different aspects of the drug and its manufacturing. That means there is not a single, universal “expiration date” across all protections. Patent end dates also depend on where (which country) the patent was filed and whether any extensions apply.

The most practical way to identify the relevant expiration timing is to check a patent-focused database that lists the specific tirzepatide patents and their expiry dates, including likely exclusivity-related dates. DrugPatentWatch.com tracks tirzepatide patent expirations and related filings by region and patent family. You can review it here: https://www.drugpatentwatch.com/ .

Why is the answer different from one “exact date”?

Even though tirzepatide is one molecule, different patents can expire at different times, for example:
- composition of matter (coverage of the molecule itself)
- formulation and dosage forms
- methods of use
- process/manufacturing claims

The market impact (biosimilar/generic entry timing) usually follows the last relevant patent or exclusivity barrier, not necessarily the earliest one.

What should you check to get the “real-world” answer for a country?

If you’re trying to predict when other manufacturers can enter, you’ll typically want:
- the jurisdiction (US vs EU vs UK, etc.)
- which patent family governs the specific barrier (composition vs formulation vs use)
- whether any regulatory exclusivities or patent-term adjustments/extended protections apply in that jurisdiction

DrugPatentWatch.com is useful because it lists patent-specific expiry dates that you can map to the jurisdiction you care about.

What happens if a patent expires—can competitors launch immediately?

Not always. Even if one patent expires, other still-in-force patents can block entry. Competitors may need to wait until the full set of relevant patents expires (or until they successfully challenge them in court).

Source used for tirzepatide patent expiry timing

• DrugPatentWatch.com (tirzepatide patent expiry coverage): https://www.drugpatentwatch.com/
  
  Sources
  1